324 related articles for article (PubMed ID: 8380812)
1. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.
Stamler JS; Osborne JA; Jaraki O; Rabbani LE; Mullins M; Singel D; Loscalzo J
J Clin Invest; 1993 Jan; 91(1):308-18. PubMed ID: 8380812
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-derived relaxing factor modulates the atherothrombogenic effects of homocysteine.
Stamler JS; Loscalzo J
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S202-4. PubMed ID: 1282970
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor.
Simon DI; Stamler JS; Jaraki O; Keaney JF; Osborne JA; Francis SA; Singel DJ; Loscalzo J
Arterioscler Thromb; 1993 Jun; 13(6):791-9. PubMed ID: 8388713
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine, EDRF, and endothelial function.
Upchurch GR; Welch GN; Loscalzo J
J Nutr; 1996 Apr; 126(4 Suppl):1290S-4S. PubMed ID: 8642473
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor.
Stamler J; Mendelsohn ME; Amarante P; Smick D; Andon N; Davies PF; Cooke JP; Loscalzo J
Circ Res; 1989 Sep; 65(3):789-95. PubMed ID: 2548765
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors.
Bassenge E
Eur Heart J; 1991 Nov; 12 Suppl E():12-5. PubMed ID: 1665128
[TBL] [Abstract][Full Text] [Related]
8. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.
Keaney JF; Simon DI; Stamler JS; Jaraki O; Scharfstein J; Vita JA; Loscalzo J
J Clin Invest; 1993 Apr; 91(4):1582-9. PubMed ID: 8473501
[TBL] [Abstract][Full Text] [Related]
9. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
[TBL] [Abstract][Full Text] [Related]
10. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.
Myers PR; Minor RL; Guerra R; Bates JN; Harrison DG
Nature; 1990 May; 345(6271):161-3. PubMed ID: 2110626
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-derived relaxant factor inhibits platelet activation.
Busse R; Lückhoff A; Bassenge E
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):566-71. PubMed ID: 2830546
[TBL] [Abstract][Full Text] [Related]
12. Synergistic disaggregation of platelets by the products of endothelial cells or their analogs.
Suzuki Y; Takami H; Tamai Y; Narita M; Mayama K; Munakata A
Haematologia (Budap); 2000; 30(2):81-90. PubMed ID: 10839560
[TBL] [Abstract][Full Text] [Related]
13. Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitrovasodilator-induced cGMP accumulation in vascular cells in culture.
Marczin N; Ryan US; Catravas JD
Circ Res; 1992 Feb; 70(2):326-40. PubMed ID: 1310448
[TBL] [Abstract][Full Text] [Related]
14. [Endothelial factors and thrombocyte function].
Schrör K
Z Kardiol; 1991; 80 Suppl 5():3-6. PubMed ID: 1776333
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Salvemini D; Currie MG; Mollace V
J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta.
Emsley AM; Jeremy JY; Gomes GN; Angelini GD; Plane F
Br J Pharmacol; 1999 Feb; 126(4):1034-40. PubMed ID: 10193785
[TBL] [Abstract][Full Text] [Related]
17. Activation of guanylate cyclase and inhibition of platelet aggregation by endothelium-derived relaxing factor released from cultured cells.
Hawkins DJ; Meyrick BO; Murray JJ
Biochim Biophys Acta; 1988 May; 969(3):289-96. PubMed ID: 2897209
[TBL] [Abstract][Full Text] [Related]
18. [Antiplatelet properties of nitrogen monoxide].
Adrie C
Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1527-32. PubMed ID: 9092414
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies on homocysteine and its metabolite-homocysteine thiolactone action in blood platelets in vitro.
Olas B; Kedzierska M; Wachowicz B
Platelets; 2008 Nov; 19(7):520-7. PubMed ID: 18979364
[TBL] [Abstract][Full Text] [Related]
20. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
